Skip to main content

09-06-2018 | SGLT2 inhibitors | Patient perspective | Article

Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’

Diabetes Therapy

Authors: Marc Evans, A Patient from Diabetes UK

Publisher: Springer Healthcare



This article, co-authored by a patient living with type 2 diabetes and a diabetes specialist physician, discusses the patient's experience of living with type 2 diabetes, including their experience of diagnosis and self-management, education and adoption of SGLT2 inhibitors to treat the disease. The physician discusses the therapeutic challenges of SGLT2 inhibitors and the importance of education.


Napp Pharmaceuticals, Ltd.

Please log in to get access to this content

Related topics

More on this topic

image credits